Displaying 680 results out of a total of 3930 publications.
PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway
Tuo, L;Xiang, J;Pan, X;Gao, Q;Zhang, G;Yang, Y;Liang, L;Xia, J;Wang, K;Tang, N;
Front Oncol, Front Oncol 8():611, 2018
View publication
Front Oncol, Front Oncol 8():611, 2018
Transient telomerase inhibition alters cell cycle kinetics
Thompson, CA;Gu, AY;Yang, SY;Mathew, V;Fleisig, H;Wong, JM;
bioRxiv, bioRxiv ():, 2017
View publication
bioRxiv, bioRxiv ():, 2017
Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action
Ribeiro, T;Lemos, F;Preto, M;Azevedo, J;Sousa, ML;Leo, PN;Campos, A;Linder, S;Vitorino, R;Vasconcelos, V;Urbatzka, R;
PLoS ONE, PLoS ONE 12(12):e0188817, 2017
View publication
PLoS ONE, PLoS ONE 12(12):e0188817, 2017
Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Alkan, O;Schoeberl, B;Shah, M;Koshkaryev, A;Heinemann, T;Drummond, DC;Yaffe, MB;Raue, A;
Sci Signal, Sci Signal 11(540):, 2018
View publication
Sci Signal, Sci Signal 11(540):, 2018
Hexosamine Biosynthetic Pathway (HBP) inhibition leads to AML cell differentiation and cell death
Asthana, A;Ramakrishnan, P;Vicioso, Y;Zhang, K;Parameswaran, R;
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2018
View publication
Mol. Cancer Ther., Mol. Cancer Ther. ():, 2018
MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
Wang, T;Liu, L;Chen, X;Shen, Y;Lian, G;Shah, N;Davidoff, AM;Yang, J;Wang, R;
Cell Death Dis, Cell Death Dis 9(2):220, 2018
View publication
Cell Death Dis, Cell Death Dis 9(2):220, 2018
Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target
Fernandez, ML;Dawson, A;Hoenisch, J;Kim, H;Bamford, S;Salamanca, C;DiMattia, G;Shepherd, T;Cremona, M;Hennessy, B;Anderson, S;Volik, S;Collins, CC;Huntsman, DG;Carey, MS;
Cancer Cell Int., Cancer Cell Int. 19():10, 2019
View publication
Cancer Cell Int., Cancer Cell Int. 19():10, 2019
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Hopkins, BD;Pauli, C;Du, X;Wang, DG;Li, X;Wu, D;Amadiume, SC;Goncalves, MD;Hodakoski, C;Lundquist, MR;Bareja, R;Ma, Y;Harris, EM;Sboner, A;Beltran, H;Rubin, MA;Mukherjee, S;Cantley, LC;
Nature, Nature ():, 2018
View publication
Nature, Nature ():, 2018
TFF3 Contributes to Epithelial-Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma Cells via the MAPK/ERK Signaling Pathway
Lin, X;Zhang, H;Dai, J;Zhang, W;Zhang, J;Xue, G;Wu, J;
J. Cancer, J. Cancer 9(23):4430-4439, 2018
View publication
J. Cancer, J. Cancer 9(23):4430-4439, 2018
ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7
Guo, T;Wen, XZ;Li, ZY;Han, HB;Zhang, CG;Bai, YH;Xing, XF;Cheng, XJ;Du, H;Hu, Y;Wang, XH;Jia, YN;Nie, ML;Xie, M;Li, QD;Ji, JF;
Cell Death Dis, Cell Death Dis 10(2):33, 2019
View publication
Cell Death Dis, Cell Death Dis 10(2):33, 2019